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ABSTRACT
Objective: This article reports on a study that used contact lenses to
simulate the effects of a visual impairment caused by age-related macular
degeneration (ARMD). The primary objective was to examine the feasibil-
ity of using this method of simulation. A secondary objective was to
compare the results from this experiment with those obtained from ARMD
patients (n = 209) using generic preference-basedmeasures (Health Utilities
Index 3 (HUI3) and EUROQOL 5 Dimensions (EQ-5D) and patient time
trade-off (TTO).
Methods: Utility values were elicited from healthy participants (n = 108)
for three ARMD states simulated using contact lenses.
Results: A signiﬁcant relationship was found between visual acuity and
TTO values elicited from our sample population (n = 108). It was stronger
than that found for HUI3, EQ-5D, and own TTO values from patients
(n = 209). Our sample values informed by the experience of simulation
were found to be signiﬁcantly different from values from patient TTO and
generic preference-based measures obtained from patients for the
same level of visual impairment. Sociodemographic characteristics did
not signiﬁcantly affect results, although baseline TTO utility values
were positively associated with TTO values for simulated states. Never-
theless, the patient population was signiﬁcantly older than the sample
population.
Conclusions: ARMD has a major impact on our sample values TTO
health state values. Differences across four visual health severity groups
appear larger than those found for a generic preference-based measure and
patient TTO values. For conditions that are difﬁcult to describe and
imagine, simulation methods may offer an additional tool when combined
with usual methods of description for obtaining better informed general
population preferences.
Keywords: age-related macular degeneration, health-related quality of life,
quality of life, United Kingdom.
Introduction
Agencies around the world responsible for informing policy sur-
rounding the reimbursement of new technologies have recom-
mended the use of general population samples for valuing health
states for use in economic evaluation. An important concern in
the valuation of hypothetical health states by members of the
general public is the extent to which participants are able to
imagine the state with any degree of accuracy [1,2] and this has
been given as one explanation for the divergence between general
population values and those from patients [3]. Some advocates of
general population values have emphasized the need to elicit
informed public values [4]. This article is concerned with the use
of innovative simulation in an attempt to establish whether it
would be possible to use this to inform participants about the
health states to be valued.
Valuation surveys typically involve presenting participants
with verbal descriptions of a set of health states. In many cases,
these are generic health state descriptions, such as those deﬁned by
the EUROQOL 5 Dimensions (EQ-5D), Health Utilities Index 3
(HUI3), or Short Form 6 Dimensions (SF-6D) [5–7]. These
descriptions tend to be quite abstract and may fail to provide
details about the condition that the participant would have
regarded as important in making their valuations. For this reason,
researchers have developed more sophisticated approaches to
describing the states, such as the use of audiotapes for impaired
speech [8], or videos of people with disabilities [9]. Although these
methodsmay be helpful, they do not actually allow the participant
to experience the state for themselves.
This article presents a novel experimental method that helps
participants experience health states similar to the condition of
age-related macular degeneration (ARMD) using contact lenses
to simulate the visual impairment, and examines the feasibility of
using this method of simulation. The values from this experiment
are then compared to those obtained from patients’ time trade-
off (TTO) and generic preference-based measures.
Background
ARMD is the leading cause of incurable blindness and visual
impairment in industrialized countries [10]. The main effect of
ARMD is to reduce the ability to engage in everyday activities
that require clear central vision (such as reading, writing, recog-
nizing people, driving, watching TV, etc.). Peripheral vision
remains unaffected so the disease does not lead to total blindness.
ARMD is a common condition that has been shown to impact
signiﬁcantly on a person’s health-related quality of life (HRQoL)
[11,12].
ARMD and other eye disorders are monitored by changes in
visual acuity (VA). In a previous study, health state values were
obtained for VA states from 209 patients with unilateral or
bilateral ARMD [12]. Patients underwent visual tests (near and
distant VA, contrast sensitivity (CS) ) and completed health
status questionnaires including the Visual Function questionnaire
(VF-14) and three generic preference-based measures (HUI3,
EQ-5D, SF-6D) and TTO for their own current state. The VF-14,
HUI3, and TTO were found to be signiﬁcantly related to VA
group (P < 0.05). This study concluded that the HUI3 was the
generic instrument of choice for use in economic evaluation
where general population values are required. Neither the
EQ-5D nor the SF-6D captured the impact of visual impairment
in the patient population. The HUI3 results from this work were
subsequently used to populate an economic model [13].
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Although the HUI3 was the best of the preference-based
measures for reﬂecting the impact of visual impairment on health
state values, it is a generic health state descriptive system. There
is a concern that its generic descriptive system may miss impor-
tant features of visual impairment caused by ARMD and its
consequences. The main effect of ARMD is to reduce the ability
of the individual to engage in everyday activities that require
clear central vision. The HUI3 has one dimension for visual
impairment but not the speciﬁc effects of ARMD. The general
population with a greater awareness of the vision impairment
caused by ARMD may give the state a different value to that
implied by the HUI3.
Alternatively, we could use a patient’s own TTO because
these should better reﬂect the impact of the condition. These
TTO values had a signiﬁcant relationship to VA in the patient
sample [11,12]. Nevertheless, most reimbursement agencies
around the world prefer general population values. TTO values
obtained directly from patients have been found to be very dif-
ferent from values generated by generic preference-based mea-
sures valued by members of the general population, such as the
HUI3. Of course, the difference between TTO and HUI3 values
does not simply reﬂect the source of values but also the fact that
they are obtained using different techniques of valuation (i.e.,
TTO and Standard Gamble, respectively). The divergence may
also arise from the fact that the HUI3 does not reﬂect the impact
of ARMD on HRQoL. This study aims to examine whether it is
possible to use contact lenses to simulate the condition and
obtain TTO values for VA states.
In a study of retinopathy states, Aballea and Tsuchiya [14]
used large plastic spectacles to simulate visual impairment. Nev-
ertheless, ARMD affects central vision and to simulate this con-
dition, spectacles would need to have an obstruction in the
middle of the glass (rather than a general blurring of the lens used
to reproduce retinopathy). Participants wearing such spectacles
would be able to largely overcome the effectiveness of the
obstruction by moving their eyes or head. Contact lenses provide
a far better method for reproducing ARMD as it should not be
normally possible to look around the central opacity on the
contact lenses. The innovative use of custom-made contact lenses
provides an opportunity for nonpatient subjects to gain a per-
sonal experience of having ARMD.
Methods
ARMD Health States
One of the primary objectives of this study was to examine the
feasibility of using contact lenses to simulate VA states similar to
ARMD and whether it would then be possible to obtain esti-
mates for the mean utility values of three visual states represent-
ing different severities of ARMD. The ARMD states were
produced by a unique method of simulating the visual impair-
ment associated with ARMD through the use of custom-made
contact lenses. The contact lenses incorporated a central opacity,
the size of which determines the degree of visual impairment and
the size of central scotoma perceived by the wearer. Custom-
made plano contact lenses (CIBA Vision, Southampton, UK) with
three different sizes of central opaque black dots were used to
approximately reproduce three vision states: VA logarithm as the
minimal angle of resolution (LogMAR) scores of 0.6 (20/80)
(reading limit), 1.0 (20/200) (legal blindness), and 1.4 (20/500)
(state to which patients with untreated ARMD deteriorate). The
lenses were sterile, single use, soft lens types, with a diameter of
14.5 mm and base curve radius of 8.1 mm. A pilot trial of the
contact lenses demonstrated the reproducibility (both between
subjects and when repeated by the same subject) of the simulated
visual states and tolerability of the lenses. The lenses were labeled
1 to 3, where lens one simulated the mildest VA impairment and
3 the most severe. The three sets of lenses were used in random
order for the simulations to minimize any order effects. Random-
ization was achieved using a random-number generator.
Sample Size and Recruitment
The relevant sample size for such a task is determined by the
required degree of precision. For this calculation, it was assumed
that a two-sided 95% conﬁdence interval (CI) of 0.05 to 0.1 either
side of the mean estimate would be sufﬁcient. Given a standard
deviation in the TTO valuation of EQ-5D score of approximately
0.25 [5], a sample size of 75 would be sufﬁcient to achieve a CI
either side of the estimate of 0.057. To allow for an attrition rate
of 25%, we aimed to recruit 100 subjects to the study.
Ethical approval for this study was obtained through School
of Health and Related Research Ethics Committee. To recruit a
representative sample of the general population of 100 subjects,
a random sample of 2000 addresses was selected across six
postcode areas around Shefﬁeld. Recruits were sent a letter
detailing the study, information sheet, and prequaliﬁcation ques-
tionnaire. Recruits were excluded if they had known ocular
pathology, high myopia (>5.00 diopters spherical equivalent),
recent increase in ﬂoaters, or any of a number of high-risk
medical complaints. This was necessary as we were using pilo-
carpine, which is associated with increased risk of adverse effects
in individuals with these conditions. We did not plan to recruit a
healthy population, but we were required to minimize risk to the
participants. A further sample of subjects was recruited via
“word-of-mouth” from participants who had completed the
study. Subjects recruited by this method were household
members, friends, or work colleagues of study subjects.
Valuation Technique
TTO was used to assess participant’s valuation of their own state
(before the lens instillation) and the three ARMD states simu-
lated by the contact lenses. The variant of TTO used in this study
was developed by the Measuring and Valuing Health (MVH)
group at University of York to value the EQ-5D [15]. The TTO
was anchored at full health and immediate death and partici-
pants were asked to choose between their current health state
and each health state.
Measurements
Baseline assessments (i.e., before having contact lenses inserted)
included measurements of VA and CS. LogMAR best-corrected
distance VA in right and left eyes was measured using the Early
Treatment Diabetic Retinopathy Study (ETDRS) chart using the
letter-by-letter scoring method. VA results are presented using
the LogMAR scale. CS was measured binocularly with a Pelli–
Robson chart (in log units) by the triplet scoring method at 1-m
distance. Recruits who were unable to score at all on CS were
assigned the minimum value on the test (0 log units). If any
participant normally wore glasses to correct their vision, they
continued to do so for their baseline assessment and the simula-
tions with the contact lenses in place.
Participants completed the interviewer-administered HUI3
questionnaire at baseline. In addition, participants completed
selected items from the VF-14 and a TTO of their current health
state. Five questions were selected from the VF-14 to be used in
this study [16]. These related speciﬁcally to the activities of daily
living which the subjects were asked to perform for each set of
lenses. These itemswere chosen as it was possible to reproduce the
activities in a standard-controlled environment in the simulation.
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Before inserting the lenses in both eyes of each recruit, an
optometrist instilled pilocarpine eye drops into each eye. The
purpose was to ensure standardization of the effect of the contact
lenses by constricting the pupil. Participants were able to famil-
iarize themselves with the effect of each set of lenses on their
vision by undertaking ﬁve activities of daily living of walking
around the room, reading a newspaper, reading a large print
book, reading a label on a food tin, and watching television.
They were questioned about their ability to perform these activi-
ties and complete a health status questionnaire before being
asked to value the state. After the insertion of each lens, partici-
pants undertook the ﬁve activities of daily living and completed
the ﬁve VF-14 items, HUI3, and TTO of the new simulated
health state.
Participants wore the lenses for between 1.5 and 2 hours
while the interview took place.
Analysis
The data used in the analysis have been adjusted for two poten-
tial confounders. First, the effect of the lenses was removed by
excluding all baseline observations (i.e., those values obtained
before inserting a lens). Each visual state will be affected in a
similar manner by the lens (and in some cases, the pilocarpine);
therefore, any difference between states should be due to the
impact on VA. The second was a possible ordering effect, such as
valuing the mild lens ﬁrst may give it and subsequent states a
lower value than valuing one of the more severe states ﬁrst.
Although the order of the three sets of lenses was randomized,
the proportion of patients experiencing the lenses in each order
was not exactly equal, so it was also necessary to remove the
ordering effect in the analysis by deﬁning dummy variables that
represent each possible ordering for the lenses and adjusting for
ordering using ordinary least squares (OLS) regression. These
adjusted TTO values were used in the main results presented in
this article.
Mean-adjusted TTO values were estimated for each lens
grouped by four health state severity levels deﬁned using distant
VA (better-seeing eye) on the LogMAR scale. The four severity
states were: 1.31 (20/400), 0.61 to 1.30 (20/80 to 20/400),
0.31 to 0.60 (20/40 to 20/80), and 0.30 (20/40). Univariate
OLS regression analyses were performed to investigate the
strength of the relationship between VA and the TTO values, and
also to examine whether demographic or clinical characteristics
or baseline TTO utility values inﬂuenced TTO valuation (speciﬁ-
cally: sex, age, marital status, employment, level of education,
method of recruitment into the study, whether long-standing
illness existed, and baseline TTO). TTO values were also com-
pared across responses to ﬁve VF-14 questions using analysis of
variance.
TTO values for the simulated ARMD states were compared
to HUI3 and TTO values obtained from a previous survey of
patients with ARMD by pooling data sets from the two studies
[12]. The patients completed, among other measures, the HUI3,
EQ-5D, and TTO and had their VA and CS tested. An overall test
of the differences between the four sources of values was per-
formed by modeling dummy variables for patients’ own TTO,
HUI3, and EQ-5D, with simulated TTO as the baseline, along-
side VA group in an OLS regression model.
Differences between the four sources of utility values are also
examined by comparing the gradient of their relationship to VA
as a continuous variable in an OLS model (Model 1). Previous
modeling of patient TTO and HUI3 data had found age to be a
signiﬁcant covariate [13], so further models were (Model 2) ﬁtted
to the four utility values with age as an explanatory variable.
A P-value of0.05 was considered statistically signiﬁcant for
all statistical tests. The statistical computer package STATA
version 9.2 (StatCorp, College Station, TX) was used for all
statistical analyses [17].
Results
Participants
A random sample of 2000 people yielded a response from only 77
participants, of which 42 participants attended to complete the
interviews. To achieve the required sample size, a further 66 were
recruited by word of mouth from colleagues and acquaintances of
study participants. The background characteristics of the sample
reﬂect this, with the mean age of the 108 participants (32 years
(SD = 12.5 years) being 7 years younger than that for the UK
population [18], with the oldest being 68 years. Sixty-six percent
were in employment at the time of the study, 9% lower than the
current UK employment rate and 28% had a university degree.
There were 25 participants (23%) with a long-standing illness.
Overall, participants were in good health, with a mean TTO value
at baseline of 0.960 (SD = 0.109 range 0.30 to 1) and a mean
HUI3 utility at baseline of 0.934 (SD = 0.105 range 0.33 to 1).
One hundred and seven (99%) had best-seeing eye VA of
0.30 LogMAR (20/40), with those needing glasses being
asked to wear them for the test. One person had a VA of between
0.31 and 0.60 (actual value 0.5) (20/40 and 20/80; actual value
20/63). The majority of participants had excellent vision, as
best-corrected VA was measured (i.e., corrected with own glasses
or contact lenses at baseline). This is also reﬂected in the
responses to the ﬁve VF-14 items, where all participants had no
problems with the activities. One person had moderate difﬁculty
reading a newspaper or book, and seven had either a little or
moderate difﬁculty reading small print.
Four of the 108 did not proceed to wearing all three sets of
the custom-made contact lenses. For three recruits, the optom-
etrist was unable to instill the contact lenses because of small
eyes, and another withdrew during testing because of severe
headache caused by the pilocarpine drops.
The distribution (N) of 104 participants across the three
lenses and the four VA best-seeing eye groups can be seen in
Table 1. A total of 41 participants achieved VA of 0.30 (20/
40) despite wearing the lenses. This may be attributable to slip-
page of the lens, allowing the central opacity to move away from
the visual axis. This group is important for estimating the impact
of VA on TTO.
For each lens, there was a distribution of participants across
the VA severity groups, and the frequency of participants varied
in the expected direction with VA. For example, the most severe
lens had more participants in the poor VA group. This variation
of VA score within each lens type may also have arisen from
contact lens slippage (which allowed the visual axis to become
uncovered due to eye movement) or incomplete pilocarpine
effect, which would have allowed the natural accommodation of
the eye to occur. This is particularly noticeable in subjects with
very dark iris pigmentation.
TTO Values by VA Group
Ordering had a signiﬁcant impact on utility values (F6,306 = 3.44,
P = 0.003). The results for the six possible orderings of the lenses
support the hypothesis that participants who valued the milder
state ﬁrst tended to give lower values overall (Table 2). There-
fore, adjustments were made for the ordering effect using the
results from the regression analysis before estimating TTO values
by VA group.
Contact Lens Simulation Study 795
Table 1 also presents mean-adjusted TTO values by lens and
VA severity group. The overall decline in mean TTO scores by
VA severity group is signiﬁcant (P < 0.001). The change in mean
values between the lowest and highest group is 0.392.
TTO Values by VF-14 Item Response
Table 3 presents the mean-adjusted utility values from partici-
pants’ responses to the ﬁve questions taken from the VF-14. For
all ﬁve VF-14 questions, the average responder’s utility values
decreased, the more they were unable to undertake an everyday
activity. The overall decline in mean TTO scores by VF-14 item
response was signiﬁcant (P < 0.001).
Background Characteristics
Sociodemographic characteristics and long-standing illness were
not signiﬁcantly related to adjusted TTO values (Table 4). The
mode of recruitment, i.e., postal survey or word of mouth rep-
resented by a dummy variable, was also not statistically signiﬁ-
cantly different. Nevertheless, after allowing for VA (best-seeing
eye), there was a signiﬁcant relationship between baseline TTO
and subsequent TTO values. Participants who gave a baseline
TTO below 1 tended to give a lower value to simulated ARMD
states (P = 0.01).
Comparison with Patient Survey
Mean-adjusted TTO values from our sample population for
simulated ARMD states were compared to those obtained from
the patient survey [12] using TTO, HUI3, and EQ-5D by VA
severity group (Table 5). The differences in mean TTO values for
simulated states and patient HUI3 were signiﬁcant for three of
the four VA groups in the pooled data set (n = 517). Differ-
ences were also signiﬁcant between TTO values for simulated
states and patients’ own TTO valuations and EQ-5D in two VA
groups. The patient TTO and HUI3 dummies were found to be
signiﬁcant.
Differences between the TTO values for simulated ARMD
states and the three sources of utility values from patients were
also examined in terms of their relationship to VA as a continu-
ous variable. The OLS regression results presented in Table 6
show clear differences between these measures in terms of the
coefﬁcient on VA. The coefﬁcient in Model 1 for TTO values for
simulated states was more than twice the size of the one for HUI3
and over four times the size of the patients’ own TTO coefﬁcient
and 13 times the coefﬁcient for EQ-5D (which was not signiﬁcant
(P > 0.05)). The addition of age (Model 2) increased the differ-
ences between the coefﬁcients on VA for the TTO values from
simulated ARMD states and for those from patients.
Discussion
The rationale for this study was that existing generic preference-
based measures of health do not adequately capture the impact
of ARMD on VF and its consequences. Even the most appro-
priate preference-based measure, the HUI3, uses a crude generic
description of VF that does not reﬂect the speciﬁc impact of
ARMD on HRQoL [12].
This study developed a unique method of simulating the
visual impairment similar to that associated with ARMD
through the use of custom-made contact lenses. For many con-
ditions, the use of simulation would be unethical. Nevertheless,
the development of the contact lenses allowed us to reproduce
some aspects of the condition in a convincing way with minimal
risk and discomfort. It enabled the study to obtain informed
preferences in a way that is rarely achieved in studies using verbal
descriptions. A previous study undertaken by Aballea and
Tsuchiya [14] sought to simulate retinopathy using specially
prepared spectacles, which represented visually impaired health
states. They found that the simulation was more effective than
written descriptions of health states in allowing participants to
imagine themselves with the condition without cognitive over-
load. Nevertheless, Aballea and Tsuchiya [14] allowed their par-
ticipants to remove the spectacles while completing the valuation
questionnaires and so this could have reduced this beneﬁt. Not
all participants chose to remove the spectacles. Our contact lens
Table 1 Mean ordering adjusted TTO scores with 95% conﬁdence interval by lens type and visual acuity (VA) group (best seeing eye)
VA LogMAR group
Lens 1 Lens 2 Lens 3
OverallReading limit Legal blindness untreated ARMD
1.31 (20/400) N = 0 N = 0 N = 56 N = 56
0.314 0.314
(0.217 to 0.410) (0.217 to 0.410)
0.61 to 1.30 (20/80 to 20/400) N = 46 N = 41 N = 38 N = 125
0.653 0.486 0.366 0.511
(0.563 to 0.743) (0.389 to 0.583) (0.246 to 0.486) (0.449 to 0.573)
0.31 to 0.60 (20/40 to 20/80) N = 40 N = 40 N = 9 N = 89
0.731 0.649 0.603 0.681
(0.662 to 0.801) (0.561 to 0.736) (0.295 to 0.912) (0.623 to 0.740)
0.30 (20/40) N = 18 N = 23 N = 0 N = 41
0.778 0.649 0.706
(0.706 to 0.851) (0.531 to 0.767) (0.606 to 0.805)
Total N = 104 N = 104 N = 103 N = 311
0.705 0.585 0.358 0.550
(0.654 to 0.755) (0.283 to 0.433) (0.283 to 0.433) (0.511 to 0.589)
ARMD, age-related macular degeneration;TTO, time trade-off.
Table 2 Adjustments for ordering effect made toTTO values (N = 313)
based on the results of a linear regression model of ordering on TTO
values
Ordering of lenses Adjustments
Order 1,2,3 (N = 48) No adjustment made
Order 1,3,2 (N = 63) Add 0.0236 to observed TTO value
Order 2,1,3 (N = 42) Subtract 0.1406 from TTO value
Order 2,3,1 (N = 63) Subtract 0.0088 from TTO value
Order 3,2,1 (N = 66) Subtract 0.1955 from TTO value
Order 3,1,2 (N = 27) Subtract 0.1817 from TTO value
Did not receive all three lenses (N = 4) Subtract 0.0002 from TTO value
TTO, time trade-off.
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study allowed participants to experience more fully the visual
restrictions of ARMD and by completing the health state valua-
tion while still experiencing the effects of the condition. We have
shown that it is possible in some subjects to simulate an eye
condition where spectacles would not have been able to repro-
duce the visual states similar to ARMD.
The contact lenses were designed to simulate a central
scotoma, the visual disturbance characterized by ARMD. Scoto-
mas which occur due to ARMD vary in size and severity and to
this end, producing contact lenses which can exactly reproduce
this effect can be difﬁcult. The contact lenses were designed to
reproduce three visual states, with different-sized scotomas. In
reality, the central scotoma which occurs as a result of ARMD is
not uniform in shape, and in addition, the scotoma may not be
complete, with area(s) of reduced but not absent vision. It was
not possible to incorporate such variables in this study; however,
future studies may wish to address these issues. Despite this, the
contact lenses did reduce central VA (which occurs with ARMD)
and a range of visual acuities were achieved with this method.
To measure scotoma size would have been preferable. Nev-
ertheless, it is not possible to objectively measure scotoma size
in subjects with ARMD or simulated ARMD states. The sub-
jective responses when measuring scotoma sizes in patients with
ARMD vary greatly upon ﬁxation, and as a result, this is often
not performed clinically, and more weight is given to objective
measures of disease state and progression (e.g., ophthalmic
photography).
We acknowledge that the different effects of pilocarpine could
be explored further by recording ethnicity (which may accountTa
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Table 4 Mean-adjusted TTO scores by demographic characteristics
with results from ANOVA after adjusting for visual acuity (distant)
Mean-adjusted TTO
score (95% CI)
F test after adjusting
for VA (P-value)
Sex:
Male 0.620 (0.562 to 0.678) 0.01 (0.944)
Female 0.624 (0.567 to 0.682)
Age:
<20 years 0.605 (0.562 to 0.678) 0.04 (0.844)
20 to 29 years 0.544 (0.471 to 0.618)
30 to 39 years 0.749 (0.675 to 0.824)
40 to 49 years 0.678 (0.564 to 0.791)
50 to 59 years 0.505 (0.352 to 0.658)
60 years 0.750 (0.589 to 0.910)
Marital status:
Single 0.589 (0.538 to 0.639) 1.30 (0.275)
Married 0.684 (0.608 to 0.761)
Separated 0.883 (0.693 to 1.000)
Divorced 0.629 (0.451 to 0.806)
Employment:
Yes 0.647 (0.600 to 0.695) 1.77 (0.184)
No 0.574 (0.497 to 0.651)
Education:
O level/GCSE 0.648 (0.576 to 0.720) 0.91 (0.459)
A level 0.623 (0.545 to 0.700)
Diploma 0.621 (0.442 to 0.801)
Degree 0.548 (0.458 to 0.639)
Masters and above 0.754 (0.617 to 0.891)
Method of recruitment:
Post 0.639 (0.572 to 0.706) 1.17 (0.281)
Word of mouth 0.612 (0.560 to 0.663)
Long-standing illness:
Yes 0.598 (0.501 to 0.695) 0.58 (0.447)
No 0.630 (0.585 to 0.674)
Baseline utility:
One 0.646 (0.599 to 0.692) 2.59 ( 0.01)
Less than one 0.545 (0.448 to 0.642)
ANOVA, analysis of variance; CI, conﬁdence interval;TTO, time trade-off;VA, visual acuity.
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for those persons with very dark iris pigmentation) and by mea-
suring the size of the pupils. Future studies may wish to consider
this.
Furthermore, the contact lenses, or the pilocarpine, may have
had an impact on participants’ valuations of the states, in addi-
tion to an impact on vision per se. There was some reported
blurring of vision on instillation of the pilocarpine drops and the
lenses were uncomfortable for some participants. The instruc-
tions given to participants when completing the health state
valuations speciﬁcally asked them to ignore the sensation of the
contact lens and any potential slight headache induced by the
pilocarpine drops. Nonetheless, participants may be responding
to the wearing of lenses rather than simply the impact on their
vision. For this reason, all baseline assessments were excluded
from the analyses. Another concern is that there may have been
an ordering effect. Although the order of lenses was randomized,
those participants who valued a mild state ﬁrst gave it a lower
value than participants who valued a more severe lens ﬁrst. The
TTO values used in the analysis were adjusted for ordering
effects.
The results of this study indicate a signiﬁcant relationship
between the visual impairment caused by the lenses, as measured
by VA, and TTO values from our sample. By comparing our
sample with a patient sample, we have drawn attention to the
potential use of a simulation method; however, the nature of the
sample and the problems encountered with the lenses themselves
make any true comparison impossible at this stage.
The study sample was not representative of the general popu-
lation and it was very different in age to the patient population.
Given the invasive nature of the task and the exclusion criteria
described in the invitation letter, it was difﬁcult to recruit to this
study from a cold sample, so it was necessary to supplement with
a word-of-mouth sample. Analysis found no signiﬁcant impact
from the sociodemographic characteristics of the participants
and their source of recruitment, but baseline TTO utility was
important. Participants with worse baseline TTO values tended
to give lower values to the simulated visual states. This result
conﬁrms the ﬁndings of Aballea and Tsuchyia [14] that the
background health of a participant can alter their responses to
the questions. Nevertheless, this effect was quite modest com-
pared to the impact of VA and only affected a minority in this
study.
The argument for using condition-speciﬁc descriptive systems
is that they better reﬂect the impact of the condition on a
patient’s quality of life. The use of condition-speciﬁc measures in
economic evaluation has been criticized for failing to achieve the
comparability across conditions required to inform resource allo-
cation [19]. Nevertheless, differences between the generic and
condition-speciﬁc measures may be a result of differences in the
methods of valuation rather than their descriptive system. Pro-
Table 5 Comparison of adjusted TTO values for ARMD simulated states compared to patient TTO, HUI3 and EQ-5D values by VA group (best seeing
eye) with 95% CI
VA LogMAR group
TTO values for ARMD
simulated states
TTO from ARMD
patients§
HUI3 from ARMD
patients§
EQ-5D from ARMD
patients§
1.31 (20/400) N = 56 N = 74 N = 76 N = 75
0.314 0.613‡ 0.233 0.695‡
(0.217 to 0.410) (0.542 to 0.680) (0.180 to 0.287) (0.647 to 0.743)
0.61 to 1.30 (20/80 to 20/400) N = 125 N = 58 N = 58 N = 58
0.511 0.665† 0.355† 0.746‡
(0.449 to 0.573) (0.588 to 0.741) (0.289 to 0.420) (0.693 to 0.799)
0.31 to 0.60 (20/40 to 20/80) N = 89 N = 39 N = 40 N = 41
0.681 0.688 0.251‡ 0.697
(0.623 to 0.740) (0.573 to 0.763) (0.298 to 0.457) (o.635 to 0.759)
0.30 (20/40) N = 41 N = 32 N = 32 N = 33
0.706 0.757 0.498‡ 0.746
(0.606 to 0.805) (0.655 to 0.858) (0.376 to 0.620) (0.6528 to 0.839)
Total N = 311 N = 203 N = 206 N = 207
0.55 0.665 0.337 0.718
(0.511 to 0.589) (0.623 to 0.707) (0.298 to 0.375) (0.688 to 0.748)
Note: Signiﬁcance of difference with TTO values for simulated ARMD states: * at 0.05 level, † at 0.01 and ‡ at 0.001.
§Source: Espallargues et al. 2005 [12].
ARMD, age-related macular degeneration; CI, conﬁdence interval; EQ-5D, EUROQOL 5 Dimensions; HUI3, Health Utilities Index 3; LogMAR, logarithm as the minimal angle of resolution;
TTO, time trade-off;VA, visual acuity.
Table 6 Estimated relationship between VA LogMAR (best-seeing eye) and measures of health state values ﬁtted using OLS regression models with
(Model 2) and without (Model 1) adjustments for age
TTO values for simulated states TTO from ARMD patients HUI3 from ARMD patients EQ-5D from ARMD patients
Regression coefﬁcient (SE) Regression coefﬁcient (SE) Regression coefﬁcient (SE) Regression coefﬁcient (SE)
Model 1
Constant 0.828 (0.039) 0.753 (0.038) 0.479 (0.033) 0.745 (0.027)
VA LogMAR -0.359 (0.045) -0.087 (0.031) -0.140 (0.027) -0.027 (0.023)
Adjusted R2 0.171 0.032 0.110 0.002
Model 2
Constant 0.860 (0.068) 1.737 (0.217) 1.078 (0.198) 0.753 (0.164)
VA LogMAR -0.368 (0.046) -0.036 (0.032) -0.109 (0.028) -0.027 (0.024)
Age -0.001 (0.002) -0.013 (0.013) -0.008 (0.003) 0.000 (0.002)
Adjusted R2 0.172 0.121 0.147 0.003
Estimates shown in bold are signiﬁcant at P < 0.01.
ARMD, age-related macular degeneration; EQ-5D, EUROQOL 5 Dimensions; HUI3, Health Utilities Index 3; LogMAR, logarithm as the minimal angle of resolution; OLS, ordinary least squares;
SE, standard error;TTO, time trade-off;VA, visual acuity.
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vided the descriptive system is valued on the same full health–
death scale using the same variant of the same valuation
technique and a comparable population sample, the valuations
should be comparable [20]. Therefore, any remaining differences
in values should be a consequence of the descriptive system.
There is a remaining concern that the value given to ARMD
states might depend on other aspects of health arising from
comorbidities. Our sample was considerably younger than the
patient study and therefore comorbidities in the older population
may be an issue. Nevertheless, an older population may be more
likely to accept natural aspects of aging and adapted as they
became older [21]. We did not have a sample that included
individuals with a range of ocular comorbidities. The patient
study would be more likely to include a fuller range of other
ocular problems including myopia, cataract, and amblyopia.
This problem must be weighed against the advantages of having
a better description of the impact of the condition (in this case, a
simulated experience of the state) than offered by the crude VF
scale of the HUI3.
The simulation approach used in this study may, with further
development, help to explain the differences observed between
patient and general population valuations, that the descriptions
provided to the latter tend to be poor [3]. Previous work on this
issue has tended to rely on the provision of verbal descriptions to
members of the general public, whereas the sample in this study
actually experienced a simulation of the state for a short time
before being asked to value it. It would have been interesting to
directly compare the vignette approach and the simulation lens
or to use a combination of lenses and vignettes to allow for fuller
descriptions of the condition which were not reproduced by the
lenses, for example, CS. It may have been possible to show that
the simulation lenses could be used in the future to obtain general
population values. The problem with slippage of the lens and
inconsistency in the achievement of VA across the participants
highlights some of the difﬁculties with the method. We recognize
that ARMD impacts on HRQoL in a number of other ways
including depression and anxiety. Nevertheless, by allowing our
subjects to experience albeit for a very short time the more severe
states, by getting them to complete tasks that they would con-
sider “normal” and reﬂect on how this would impact on how
they would function with ARMD was arguably more effective
than the usual descriptive methods.
This study found that ARMD has a major impact on the
sample population TTO health state values. Differences across
four visual severity states appear larger than those found for
generic preference-based measures and patient TTO values.
Sociodemographic characteristics were not found to be signiﬁ-
cant factors in inﬂuencing the simulated utility values, although
baseline TTO utility values were positively associated with sub-
sequent TTO values for simulated states. For conditions that are
difﬁcult to describe and imagine, such as ARMD, simulation
methods may offer an important method for obtaining better
informed general population preferences. Further validation
work comparing or combining vignettes and contact lens simu-
lation methods may make it possible to use this method in the
future to obtain general population values for an important
health condition.
Source of ﬁnancial support: We acknowledge the receipt of a grant from
Novartis UK to complete this work.
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